Daniel Hoyer, Professor of The University of Melbourne, Melbourne, Australia. Professor Daniel Hoyer, Chair and Head of the Department of Pharmacology and Therapeutics, was awarded the Maurice Rapport Prize and delivered the Rapport Plenary Lecture at the 2016 International Society of Serotonin Research (ISSR) Meeting.Before joining the University of Melbourne in 2012, Professor Hoyer had a long and distinguished career in academia and industry: after his PhD and DSc from Strasbourg University and a post doctorate at the University of Pennsylvania Medical School, he joined the multinational pharmaceutical company Sandoz, then Novartis in Basel. He is an Honorary Professorial Fellow at the Florey Institute of Neuroscience and Mental Health and an Adjunct Professor in the Department of Chemical Physiology at the Scripps Research Institute in La Jolla, California.In his current role at the University of Melbourne, Professor Hoyer – in collaboration with Monash University’s Professor William Charman– led the establishment of Project Mercury, a historic $80 million partnership between the two universities and the Victorian state government to accelerate translational research, drug development and commercialisation. The joint venture, BioCurate Pty Ltd, was incorporated on 10 August 2016, under the chairmanship of the Hon. John Brumby, former Premier of Victoria.